{
  "$schema": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/QualificationPlan/v3.3/schemas/OSP_Qualification_Plan_Schema.json",
  "Projects": [
    {
      "Id": "Fluvoxamine",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Model/alt_v1.0/Fluvoxamine-Model.json"
    },
    {
      "Id": "Moclobemide",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Moclobemide-Model/v2.0/Moclobemide-Model.json"
    },
    {
      "Id": "Omeprazole",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Omeprazole-Model/v2.0/Omeprazole-Model.json"
    },
    {
      "Id": "S_Mephenytoin",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/S-Mephenytoin-Model/v2.0/S_Mephenytoin-Model.json"
    },
    {
      "Id": "Omeprazole-Fluvoxamine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Omeprazole-DDI/v1.1/Fluvoxamine-Omeprazole-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Esomeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "Omeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "R-omeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Formulation",
          "Name": "Omeprazole capsule",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Omeprazole-Moclobemide-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Moclobemide-Omeprazole-DDI/v1.1/Moclobemide-Omeprazole-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Esomeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "Omeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "R-omeprazole",
          "Project": "Omeprazole"
        },
        {
          "Type": "Formulation",
          "Name": "Omeprazole capsule",
          "Project": "Omeprazole"
        },
        {
          "Type": "Compound",
          "Name": "Moclobemide",
          "Project": "Moclobemide"
        },
        {
          "Type": "Formulation",
          "Name": "Moclobemide tablet",
          "Project": "Moclobemide"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "S-mephenytoin-Fluvoxamine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-S-mephenytoin-DDI/v1.1/Fluvoxamine-S-mephenytoin-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "S-Mephenytoin",
          "Project": "S_Mephenytoin"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": []
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "DDI Ratios",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Database-for-observed-data/v1.7/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AllPlots": [],
    "GOFMergedPlots": [],
    "ComparisonTimeProfilePlots": [
      {
        "SectionReference": "omeprazole-moclobemide-ddi",
        "Title": "Cho 2002 (Omeprazole 40 mg po) Asian EM",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "omeprazole 40mg po asian EM",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Cho2002.Mean Ompz.20mg.po.EM",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Moclobemide)",
            "Symbol": "Circle"
          },
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "omeprazole 40mg po asian EM moclobemide 300mg po",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Cho2002.Mean Ompz+Moc.20mg.po.EM",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Moclobemide",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "omeprazole-moclobemide-ddi",
        "Title": "Cho 2002 (Omeprazole 40 mg po) Asian PM",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "omeprazole 40mg po asian PM",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Cho2002.Mean Ompz.20mg.po.PM",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Moclobemide)",
            "Symbol": "Circle"
          },
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "omeprazole 40mg po asian PM moclobemide 300mg po",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Cho2002.Mean Ompz+Moc.20mg.po.PM",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Moclobemide",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "omeprazole-fluvoxamine-ddi",
        "Title": "Yasui-Furukori 2004 (Omeprazole 40 mg po) Asian EM",
        "SimulationDuration": 128,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Omeprazole-Fluvoxamine-DDI",
            "Simulation": "omeprazole 40mg po asian EM",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui-Furukori2004.omeprazole.40mg.po.japanese hmEM 1",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Omeprazole-Fluvoxamine-DDI",
            "Simulation": "omeprazole 40mg po asian EM fluvoxamine 50mg po",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui-Furukori2004.omeprazole+fluvox.40mg.po.japanese hmEM 1",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "omeprazole-fluvoxamine-ddi",
        "Title": "Yasui-Furukori 2004 (Omeprazole 40 mg po) Asian PM",
        "SimulationDuration": 128,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Omeprazole-Fluvoxamine-DDI",
            "Simulation": "omeprazole 40mg po asian PM",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui-Furukori2004.omeprazole.40mg.po.japanese PM 1",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Omeprazole-Fluvoxamine-DDI",
            "Simulation": "omeprazole 40mg po asian PM fluvoxamine 50mg po",
            "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui-Furukori2004.omeprazole+fluvox.40mg.po.japanese PM 1",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "s-mephenytoin-fluvoxamine-ddi",
        "Title": "Yao 2003 (S-Mephenytoin 100 mg po)",
        "SimulationDuration": 180,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "S-mephenytoin-Fluvoxamine-DDI",
            "Simulation": "S-Mephenytoin 100mg po",
            "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yao et al.2003.S-Mephenytoine 100 mg po without Fluvoxamine",
            "StartTime": 176,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "S-mephenytoin-Fluvoxamine-DDI",
            "Simulation": "S-Mephenytoin 100mg po fluvoxamine 27.5mg po",
            "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yao et al.2003.S-Mephenytoine 100 mg po with 37.5 mg/day Fluvoxamine",
            "StartTime": 176,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (27.5 mg Fluvoxamine)",
            "Symbol": "Square"
          },
          {
            "Project": "S-mephenytoin-Fluvoxamine-DDI",
            "Simulation": "S-Mephenytoin 100mg po fluvoxamine 45.8mg po",
            "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yao et al.2003.S-Mephenytoine 100 mg po with 62.5 mg/day Fluvoxamine",
            "StartTime": 176,
            "TimeUnit": "h",
            "Color": "#00b33c",
            "Caption": "Treatment (45.8 mg Fluvoxamine)",
            "Symbol": "Cross"
          },
          {
            "Project": "S-mephenytoin-Fluvoxamine-DDI",
            "Simulation": "S-Mephenytoin 100mg po fluvoxamine 64.1mg po",
            "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yao et al.2003.S-Mephenytoine 100 mg po with 87.5 mg/day Fluvoxamine",
            "StartTime": 176,
            "TimeUnit": "h",
            "Color": "#FF0000",
            "Caption": "Treatment (64.1 mg Fluvoxamine)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionReference": "moclobemide-omeprazole-ddi",
        "Title": "Yu 2001 (Moclobemide 300 mg po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "moclobemide 300mg po asian EM",
            "Output": "Organism|PeripheralVenousBlood|Moclobemide|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu2001.Asian.Moclobemide.300.po.sd.EM",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Omeprazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Omeprazole-Moclobemide-DDI",
            "Simulation": "omeprazole 40mg po asian EM moclobemide 300mg po",
            "Output": "Organism|PeripheralVenousBlood|Moclobemide|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu2001.Asian.Moclobemide.300.po.sd.EM+OMP40sd",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (40 mg Omeparzole)",
            "Symbol": "Square"
          }
        ]
      }
    ],
    "DDIRatioPlots": [
      {
        "SectionReference": "qualification-of-cyp2c19-mediated-ddi",
        "Title": "CYP2C19 DDI",
        "PKParameters": [
          "AUC",
          "CMAX"
        ],
        "PlotTypes": [
          "predictedVsObserved",
          "residualsVsObserved"
        ],
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure",
          "Table"
        ],
        "Subunits": [
          "Perpetrator",
          "Victim"
        ],
        "Groups": [
          {
            "Caption": "Omeprazole + Fluvoxamine (EM)",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 11050,
                "SimulationControl": {
                  "Project": "Omeprazole-Fluvoxamine-DDI",
                  "Simulation": "omeprazole 40mg po asian EM",
                  "StartTime": 120,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Omeprazole-Fluvoxamine-DDI",
                  "Simulation": "omeprazole 40mg po asian EM fluvoxamine 50mg po",
                  "StartTime": 120,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Omeprazole + Fluvoxamine (PM)",
            "Color": "#008000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 11052,
                "SimulationControl": {
                  "Project": "Omeprazole-Fluvoxamine-DDI",
                  "Simulation": "omeprazole 40mg po asian PM",
                  "StartTime": 120,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Omeprazole-Fluvoxamine-DDI",
                  "Simulation": "omeprazole 40mg po asian PM fluvoxamine 50mg po",
                  "StartTime": 120,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Omeprazole + Moclobemide (EM)",
            "Color": "#b2182b",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 11048,
                "SimulationControl": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "omeprazole 40mg po asian EM",
                  "StartTime": 0,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "omeprazole 40mg po asian EM moclobemide 300mg po",
                  "StartTime": 0,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Omeprazole + Moclobemide (PM)",
            "Color": "#003300",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 11049,
                "SimulationControl": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "omeprazole 40mg po asian PM",
                  "StartTime": 0,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "omeprazole 40mg po asian PM moclobemide 300mg po",
                  "StartTime": 0,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "S-Mephenytoin + Fluvoxamine 27.5 mg",
            "Color": "#0000FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 15001,
                "SimulationControl": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po fluvoxamine 27.5mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "S-Mephenytoin + Fluvoxamine 45.8 mg",
            "Color": "#FF00FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 15002,
                "SimulationControl": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po fluvoxamine 45.8mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "S-Mephenytoin + Fluvoxamine 64.1 mg",
            "Color": "#00C0C0",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|S-Mephenytoin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 15003,
                "SimulationControl": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "S-mephenytoin-Fluvoxamine-DDI",
                  "Simulation": "S-Mephenytoin 100mg po fluvoxamine 64.1mg po",
                  "StartTime": 176,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Moclobemide + Omeprazole",
            "Color": "#FF8000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Moclobemide|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 10027,
                "SimulationControl": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "moclobemide 300mg po asian EM",
                  "StartTime": 0,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Omeprazole-Moclobemide-DDI",
                  "Simulation": "omeprazole 40mg po asian EM moclobemide 300mg po",
                  "StartTime": 0,
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ]
  },
  "Inputs": [],
  "Sections": [
    {
      "Reference": "introduction",
      "Title": "Introduction",
      "Sections": [
        {
          "Reference": "objective",
          "Title": "Objective",
          "Content": "Content/Qualification_objective.md"
        },
        {
          "Reference": "cyp2c19-ddi-network",
          "Title": "CYP2C19 DDI Network",
          "Content": "Content/Qualification_DDI_network_description.md",
          "Sections": [
            {
              "Reference": "network-omeprazole-moclobemide-ddi",
              "Title": "Omeprazole - Moclobemide DDI",
              "Content": "Content/Omeprazole-Moclobemide-DDI.md"
            },
            {
              "Reference": "network-omeprazole-fluvoxamine-ddi",
              "Title": "Omeprazole - Fluvoxamine DDI",
              "Content": "Content/Omeprazole-Fluvoxamine-DDI.md"
            },
            {
              "Reference": "network-s-mephenytoin-fluvoxamine-ddi",
              "Title": "S-Mephenytoin - Fluvoxamine DDI",
              "Content": "Content/S-Mephenytoin-Fluvoxamine-DDI.md"
            },
            {
              "Reference": "network-moclobemide-omeprazole-ddi",
              "Title": "Moclobemide - Omeprazole DDI",
              "Content": "Content/Moclobemide-Omeprazole-DDI.md"
            }
          ]
        }
      ]
    },
    {
      "Reference": "qualification-of-cyp2c19-mediated-ddi",
      "Title": "Qualification of Use Case CYP2C19-mediated DDI",
      "Content": "Content/Intro_evaluation_DDI_network.md"
    },
    {
      "Reference": "ct-profiles",
      "Title": "Concentration-Time Profiles",
      "Content": "Content/Intro_evaluation_CTprofiles.md",
      "Sections": [
        {
          "Reference": "omeprazole-moclobemide-ddi",
          "Title": "Omeprazole - Moclobemide DDI"
        },
        {
          "Reference": "omeprazole-fluvoxamine-ddi",
          "Title": "Omeprazole - Fluvoxamine DDI"
        },
        {
          "Reference": "s-mephenytoin-fluvoxamine-ddi",
          "Title": "S-Mephenytoin - Fluvoxamine DDI"
        },
        {
          "Reference": "moclobemide-omeprazole-ddi",
          "Title": "Moclobemide - Omeprazole DDI"
        }
      ]
    },
    {
      "Reference": "conclusion",
      "Title": "Conclusion",
      "Content": "Content/Section4_Conclusion.md",
      "Sections": []
    },
    {
      "Reference": "main-references",
      "Title": "References",
      "Content": "Content/References.md",
      "Sections": []
    },
    {
      "Reference": "appendix",
      "Title": "Appendix",
      "Sections": [
        {
          "Reference": "osp-introduction",
          "Title": "Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/OSPS_Introduction.md"
        },
        {
          "Reference": "mathematical-implementation-of-ddi",
          "Title": "Mathematical Implementation of Drug-Drug Interactions",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Mathematical_Implementation_of_DDI.md"
        },
        {
          "Reference": "automatic-requalification-workflow",
          "Title": "Automatic (re)-qualification workflow",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Qualification_Workflow.md"
        }
      ]
    },
    {
      "Reference": "glossary",
      "Title": "Glossary",
      "Content": "Content/glossary.md"
    }
  ],
  "Intro": [
    {
      "Path": "Content/titlepage.md"
    }
  ]
}